Home Great North Bike Ride Waggonways To health Cycle Ride Jingle Bell Walk Poems from the heart Christopher's Story
Counselling Contact Us Sign our guestbook Ways to donate and support Sponsor an event Wish list Charity information
|
LATEST NEWS Just been donated some collection boxes could any of you out there take to work/local pub/shop etc every penny counts towards finding a cure!
27th November 2008 Sadly Alice passed away Words cannot express how we feel about this tragic loss our thoughts are with Alice's family. your left foot isn’t normalSearch all Alice Bullock's films
|
|||||||
| November 3rd 2008 | |||||||
| Cycle Perth to Sydney | |||||||
Martin Lisle is going to cycle solo unassisted from Perth to Sydney on behalf of the Chris Lucas Trust a staggering distance of 2,724 miles via Adelaide and Melbourne starting in Jan 09. It will be the Australian summer with average temperatures in the 30s and a small matter of crossing the 800 mile Nullarbor Desert. All money raised goes to The Chris Lucas Trust Martin's aim is raise one pound for every mile on the bike. Martin needs your help to make his fundraising a huge success! Donating through Justgiving is
quick, easy and totally secure. It’s also the most efficient way
to sponsor Martin: Chris Lucas Trust gets your money faster and,
if you’re a UK taxpayer, Justgiving makes sure 25% in Gift Aid,
plus a 3% supplement, are added to your donation. http://www.justgiving.com/martinlisle
|
|||||||
| August 27th 2008 | |||||||
| GREAT NORTH BIKE RIDE 2008 | |||||||
| Sunday 24 August 2008. A STAGGERING 2000
cyclists took part in the Great North Bike Ride, The biggest
cycle ride in the North-east and Scotland! BBC's Alan Clarke went out to take photos at the start, along the route and at the finish. Here are the cyclists setting off from Seahouses.
PICTURES 2008 A super collection by Alan Clarke
|
|||||||
| May 15th 2008 | |||||||
|
Senior Scientist exclusively funded by Chris Lucas Trust for Rhabdomyosarcom (RMS) |
|||||||
|
By Lynn Lucas On behalf of the Chris Lucas Trust we are delighted to announce we have extended the contract of our senior post doctoral scientist a further 3 years to work exclusively on Rhabdomyosarcoma (RMS) on behal of the Chris Lucas Trust, the charity has exclusively funded this position since 2005 based at the Royal Marsden Hospital, London, Institute of Cancer Research, Innovative Therapies for Children with Cancer (ITCC)
The institute was chosen as the 'rhabdomyosarcoma
biology lab' for a new European consortium called
Innovative Therapies for Children with Cancer (ITCC) Professor Andy Pearson who was appointed February 1st 2005. to the Chair, at this institute, focussing on clinical trials of new drugs and will certainly be linked with our vital work on rhabdomyosarcoma, and he is very supportive of this, so the Newcastle link with this centre will be even stronger.
The institute was chosen as the 'rhabdomyosarcoma
biology lab' for a new European consortium called
Innovative Therapies for Children with Cancer (ITCC) Professor Andy Pearson is Chair, at this institute, focussing on clinical trials of new drugs and will certainly be linked with our vital work on rhabdomyosarcoma, and he is very supportive of this, so the Newcastle link with this centre will be even stronger. We are leading in the area of testing existing new drugs for activity against rhabdomyosarcoma. Our research group is also very interested in the underlying molecular abnormalities in RMS that might be important as targets for developing new drugs.
Dr Kathy Pritchard -Jones, and Dr Janet Shipley, who
leads the molecular cytogenetics group, are planning
several interacting projects on rhabdomyosarcoma, all of
which aim to help identify new, effective drug targets
and treatment for this dreadful disease..
By looking at how these results predict response to
treatment, we aim to highlight the important genes for
choosing new drugs to test on RMS cell lines and in the
clinic and aim to identify new targets for
developing new drugs. 25th April 2008 Title: Identification of therapeutic targets through genomic and expression profiling rhabdomyosarcomas Report by: Dr. Edoardo Missiaglia, Dr. Janet Shipley and Professor Kathy Pritchard-Jones, The Institute of Cancer Research/Royal Marsden Hospital NHS Trust, Sutton, Surrey Date: 25th April 2008 Lay summary Rhabdomyosarcomas are rare cancers but are one of the leading causes of death from cancer in children. Our aim is to understand the mechanisms that lead a normal cell to develop into a rhabdomyosarcoma in order to improve the treatment of children with these tumours. Genes produce “messages” which are usually converted in molecules that perform specific tasks inside the cells that make up our body. Genes may produce too much, too little or even wrong “messages”, that can lead a cell to become cancerous. We are using techniques that measure the levels of these “messages” from thousands of different genes and also molecules called microRNAs which modify the levels of these “messages” in cells. We have made great progress in screening samples of rhabdomyosarcomas for these changes in collaboration with other experts in the field. Our preliminary analysis has already identified genes for further investigation and we have prepared a scientific manuscript that will report our findings. Further genes will be identified and experiments will determine the role these play in the development of rhabdomyosarcomas. These may represent molecular targets specific to the tumours and lead to novel therapeutic treatments for children with rhabdomyosarcoma. We are indebted to the Chris Lucas Trust for supporting this research.
|
|||||||
|
CYCLETHON 12 HOURS AT ASDA
|
|||||||
|
BIG HEARTED CYCLIST'S FUNDRAISED FOR 12 HOURS FOR THE CHRIS LUCAS TRUST, AT ASDA LONGBENTON, TYNE AND WEAR.
| |||||||